Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Contributeurs/tricesAddeo, Alfredo; Shah, Pankil K.; Bordry, Natacha; Hudson, Robert D.; Albracht, Brenna; Di Marco, Mariagrazia; Kaklamani, Virginia; Dietrich, Pierre-Yves; Taylor, Barbara S.; Simand, Pierre-Francois; Patel, Darpan; Wang, Jing; Labidi-Galy, Sana Intidhar; Fertani, Sara; Leach, Robin J.; Sandoval, Jose; Mesa, Ruben; Lathrop, Kate; Mach, Nicolas; Shah, Dimpy P.
Publié dansCancer Cell, vol. 39, no. 8, p. 1091-1098.e2
Date de publication2021
Résumé
Mots-clés
- COVID-19
- Anti-cancer treatment
- Antibody
- Immune response
- Malignancy
- Oncology
- Pandemic
- Seroconversion
- Tumor
- Vaccine
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
ADDEO, Alfredo et al. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. In: Cancer Cell, 2021, vol. 39, n° 8, p. 1091–1098.e2. doi: 10.1016/j.ccell.2021.06.009
Fichiers principaux (1)
Article (Published version)
Fichiers secondaires (1)
Identifiants
- PID : unige:155812
- DOI : 10.1016/j.ccell.2021.06.009
- PMID : 34214473
Jeu de données
ISSN du journal1535-6108